• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    The TAC is in search of a Mental Health/SUD Professional. Go to Technical Advisory Committee Page for more information.​

    PMDP circle.jpg ​Maryland
    Prescription Drug​ Monitoring Program

    ​​​​The Prescription Drug Monitoring Program, or PDMP, was established to support healthcare providers and their patients in the safe and effective use of prescription drugs. The PDMP collects and securely stores information on drugs that contain controlled substances and are dispensed to patients in Maryland. Use of prescription information improves providers’ ability to manage the benefits and risks of controlled substance medications and identify potentially harmful drug interactions. The PDMP is a core component of the State’s and many local jurisdictions’ strategies for reducing drug-related overdoses. 

    For general information about the PDMP, see the Frequently Asked Questions​ section. For​ information about clinical user access to PDMP data, please view the PDMP Training Video. If you have additional questions, please contact the PDMP​

    ​​​

    ​​​​​​​​​

    Healthcare Provider Registration

    Click on the CRISP logo for access to the CRISP Registration Page

    ​​​​​______________________________

    Dispenser Reporting

    Select the RxGov image below to access the Data Submitter Reference Guide

    Data Submitter Reference Guide 2.jpg

    Click here​ for updates on the Dispenser migration from RxSentry to RxGov,​​ that began April 2019 ​